L'Alerte : Bulletin de liaison de la région lyonnaise

1930/08 (A2,N14)-1930/09.

L'Alerte : Bulletin de liaison de la région lyonnaise

1930/10 (A2,N15).

L'Alerte : Bulletin de liaison de la région lyonnaise

1930/07/01 (A2,N13).

L'Alerte : Bulletin de liaison de la région lyonnaise

1930/06/01 (A2,N11).

L'Alerte : Bulletin de liaison de la région lyonnaise

1930/06/22 (A2,N12).

Almanach de l'Action française

1910 (A2).

Almanach des spectacles ... : contenant une notice sur les principaux théâtres de Paris depuis le commencement du dix-neuvième siècle ; l'histoire de l'origine et de l'établissement de chacun de ceux qui existent aujourd'hui ; personnel, répertoire, pièces nouvelles, débuts, etc. etc. ; principaux théâtres de France et de l'étranger ; jardins, établissemens publics de tout genre ; prix des places, etc., etc. : ouvrage utile aux étrangers et à toutes les personnes qui fréquentent les spectacles

1823 (A2).

L'Ami des sciences / par Victor Meunier

1856 (A2,T2).

Estimates of genetic parameters for fruit yield and quality in custard apple progenies

Apparently, there are no custard apple cultivars defined for the northeastern region of Brazil. The establishment of breeding programs aimed at the selection of types from productive locations for later cloning is desirable. This work's objective was to evaluate the yield (during the first three crops) and quality (first crop) of fruits from 20 half-sibling custard apple tree progenies, selected from home orchards. An additional objective was to estimate genetic parameters for the traits evaluated. A micro sprinkling-irrigated experiment was conducted in Mossoró-RN, Brazil, as random blocks with five replications. In characteristics evaluated for periods longer than a year (diameter, height and mean weight of fruits, number of fruits ha-1 and fruit yield (kg ha-1), and a split-plot design was adopted, with progenies considered as plots and annual cropping seasons as subplots. The best progenies in terms of fruit yield (A3 and A4) are not necessarily the best for fruit dimensions and fruit mean weight (A2, FE4, JG1, JG2, SM1, SM7, and SM8). These progenies show great potential to be used in future studies on crosses or on vegetative propagation. In this regard, progeny JG2 should be highlighted as promising in terms of yield and fruit size. The progenies are not different with regard to percentages (in relation to mean fruit mass) of pericarp, endocarp, seeds, and receptacle, in the fruit, and fruit volume, number of seeds/fruit, and total soluble solids content in the fruit pulp, but progeny FE4 presents higher total titratable acidity in the fruit pulp. Narrow-sense heritability estimates were relatively high for all characteristics in which there was variability between progenies, with higher values for number of fruits ha-1 (80 %) and fruit yield (78 %). Relatively high coefficients of genotypic variation (around 20%) were observed for number of fruits ha-1 and fruit yield, with lower values for the other characteristics. There were positive genotypic and phenotypic correlations between fruit diameter (FD) and fruit height, FD and mean fruit weight, and number of fruits ha-1 and fruit yield.

Zoneamento agroclimático da cultura da mangueira no Estado do Piauí

O presente trabalho teve como objetivo realizar o zoneamento agroclimático da cultura da mangueira no Estado do Piauí. Foram utilizados dados médios anuais de precipitação e temperatura do ar, de 15 municípios do Piauí, representativos das principais regiões do Estado para a elaboração do balanço hídrico e a obtenção do Índice de Umidade (Im). Foram adotadas as seguintes faixas de Índice de Umidade (Im): - Aptidão plena A, Im < -40; - Aptidão plena B, -40 < Im <-20. O critério utilizado na divisão do Estado, em zonas térmicas, baseou-se nas normais de temperaturas médias do mês mais quente (Tq) para cada local. Assim sendo, as faixas A e B, com aptidão plena, do ponto de vista hídrico, foram subdivididas em duas subzonas: Aptidão plena A1: (Tq < 29 ºC), Aptidão plena A2: (29 ºC < Tq <31 ºC) e Aptidão plena B1: (Tq < 29 ºC), Aptidão plena B2: (29 ºC < Tq <31 ºC), para atender ao critério térmico. Com base nas cartas de Tq e Im, foram definidos os limites para as diferentes zonas de aptidão climáticas para o cultivo de manga. À luz dos critérios utilizados e com base na literatura consultada, o Estado do Piauí não apresenta nenhuma restrição climática para o cultivo comercial da mangueira.

Diferentes espaçamentos de plantio e níveis de adubação sobre a atividade da redutase do nitrato em folhas do híbrido de mamoeiro UENF/CALIMAN-01

O objetivo deste trabalho foi avaliar o efeito de diferentes espaçamentos de plantio e de níveis de adubação NPK sobre a atividade da redutase do nitrato (RN) nas folhas do híbrido de mamoeiro UENF/CALIMAN-01 , visando a sugerir possível ajuste em seu manejo de adubação nitrogenada, no sentido de maximizar a eficiência do uso do nitrogênio. O experimento foi conduzido na fazenda Caliman Agrícola S.A., no município de Linhares - ES. Utilizou-se o delineamento estatístico experimental em blocos casualizados, com esquema fatorial, com três espaçamentos de plantio entre plantas (E1 = 1,8 m; E2 = 2,25 m, e E3 = 2,7 m), cinco níveis de adubação NPK convencional (A1 = 80% do padrão; A2 = 100% padrão da empresa; A3 = 120% do padrão; A4 = 140% do padrão, e A5 = 160% do padrão) e cinco períodos de avaliação (meses de março a julho). O padrão de adubação NPK da empresa consiste em 350; 105 e 660 kg ha-1ano-1 de sulfato de amônio (20% de N), superfosfato simples (18% de P) e cloreto de potássio (60% de K), respectivamente. Os dados obtidos para a atividade da RN foram submetidos a uma análise de variância e teste de médias. Dentre os tratamentos testados, o nível A1 (80% do padrão), independentemente do espaçamento, poderia ser indicado no manejo do híbrido de mamoeiro UENF/CALIMAN-01, pois em todos eles a atividade da redutase do nitrato, em praticamente todos os períodos avaliados, apresentou valores adequados, ou até mesmo superiores aos encontrados na literatura em cultivares de mamoeiro. A redução da adubação NPK pôde ser justificada, uma vez que não houve diferença na produtividade das plantas entre os tratamentos avaliados.

Manejo da cultura do híbrido de mamoeiro (Carica papaya L.) do grupo 'Formosa' UENF/CALIMAN : 01 para melhoria na qualidade do fruto com menor aplicação de adubação NPK

O presente trabalho teve como objetivo avaliar o efeito de alguns aspectos do manejo da cultura do mamoeiro como espaçamento e nível de adubação NPK, sobre alguns atributos de qualidade dos frutos do híbrido do grupo 'Formosa' UENF/CALIMAN-01(UC01). O experimento foi conduzido na fazenda Caliman Agrícola S.A., em Linhares-ES. Utilizou-se o delineamento estatístico experimental em blocos casualizados, com esquema fatorial, com três espaçamentos de plantio entre plantas (E1 = 1,80 m; E2 = 2,25 m, e E3 = 2,70 m), cinco níveis de adubação NPK convencional (A1 = 80% do padrão da empresa (PE); A2 = 100% PE; A3 = 120% PE; A4 = 140% PE, e A5 = 160% PE), e três períodos de avaliação (junho, agosto e outubro de 2007). O padrão de adubação NPK da empresa (PE) consiste em 350; 105 e 660 kg ha-1ano-1 de sulfato de amônio (20% de N), superfosfato simples (18% de P2O5) e cloreto de potássio (60% de K2O), respectivamente. Foram analisados a firmeza do fruto e da polpa, a concentração de sólidos solúveis (SS), o pH, a acidez titulável (AT) e a razão SS/AT da polpa. Os dados foram submetidos à análise de variância e teste de médias. Os resultados mostram que, entre as condições de espaçamento e níveis de adubação NPK testados, o melhor desempenho foi obtido pelas combinações E1A1 ou E2A1, os quais devem ser adotadas para o manejo do híbrido UC01. Os tratamentos resultaram em frutos com atributos de qualidade superiores, além de proporcionar redução nos gastos com adubação NPK e menor impacto ambiental em função da aplicação excessiva de adubo no solo.

Preferência para oviposição e ciclo de vida de mosca-negra- dos-citros Aleurocanthus woglumi Ashby em espécies frutíferas

Aleurocanthus woglumi Ashby conhecida popularmente como mosca-negra-dos-citros é considerada praga quarentenária A2 no Brasil e ocasiona prejuízo em diversas frutíferas, principalmente em citros (laranja, limão e tangerina). Poucas são as pesquisas relacionadas aos seus aspectos biológicos nas condições ambientais brasileiras. Nesse sentido, o objetivo da pesquisa foi verificar a preferência de oviposição e a duração do ciclo de vida de A. woglumi em diferentes hospedeiros. A pesquisa foi conduzida em casa de vegetação, durante o período de março de 2009 a março de 2010. Foram realizados testes de preferência sem chance de escolha em seis hospedeiros, simultaneamente, em períodos de 48 e 72 horas, além da biologia comparada em mangueira e laranjeira. Foram observados nos testes que A. woglumi apresenta preferência por ovipositar nas espécies cítricas (limoeiro, laranjeira e tangerineira), mantendo um padrão de não preferência em cajueiro e goiabeira. Os hospedeiros laranjeira e mangueira não interferiram no ciclo biológico da praga.

The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy.

PURPOSE: Chemokines are implicated in T-cell trafficking. We mapped the chemokine landscape in advanced stage ovarian cancer and characterized the expression of cognate receptors in autologous dendritic cell (DC)-vaccine primed T cells in the context of cell-based immunotherapy. EXPERIMENTAL DESIGN: The expression of all known human chemokines in patients with primary ovarian cancer was analyzed on two independent microarray datasets and validated on tissue microarray. Peripheral blood T cells from five HLA-A2 patients with recurrent ovarian cancer, who previously received autologous tumor DC vaccine, underwent CD3/CD28 costimulation and expansion ex vivo. Tumor-specific T cells were identified by HER2/neu pentamer staining and were evaluated for the expression and functionality of chemokine receptors important for homing to ovarian cancer. RESULTS: The chemokine landscape of ovarian cancer is heterogeneous with high expression of known lymphocyte-recruiting chemokines (CCL2, CCL4, and CCL5) in tumors with intraepithelial T cells, whereas CXCL10, CXCL12, and CXCL16 are expressed quasi-universally, including in tumors lacking tumor-infiltrating T cells. DC-vaccine primed T cells were found to express the cognate receptors for the above chemokines. Ex vivo CD3/CD28 costimulation and expansion of vaccine-primed Tcells upregulated CXCR3 and CXCR4, and enhanced their migration toward universally expressed chemokines in ovarian cancer. CONCLUSIONS: DC-primed tumor-specific T cells are armed with the appropriate receptors to migrate toward universal ovarian cancer chemokines, and these receptors are further upregulated by ex vivo CD3/CD28 costimulation, which render T cells more fit for migrating toward these chemokines. Clin Cancer Res; 21(12); 2840-50. ©2015 AACR.

Optimising approaches to active immunotherapy of cancer

The design of therapeutic cancer vaccines is aimed at inducing high numbers and potent T cells that are able to target and eradicate malignant cells. This calls for close collaboration between cells of the innate immune system, in particular dendritic cells (DCs), and cells of the adaptive immune system, notably CD4+ helper T cells and CD8+ cytotoxic T cells. Therapeutic vaccines are aided by adjuvants, which can be, for example, Toll¬like Receptor agonists or agents promoting the cytosolic delivery of antigens, among others. Vaccination with long synthetic peptides (LSPs) is a promising strategy, as the requirement for their intracellular processing will mainly target LSPs to professional antigen presenting cells (APCs), hence avoiding the immune tolerance elicited by the presentation of antigens by non-professional APCs. The unique property of antigen cross-processing and cross-presentation activity by DCs plays an important role in eliciting antitumour immunity given that antigens from engulfed dead tumour cells require this distinct biological process to be processed and presented to CD8+T cells in the context of MHC class I molecules. DCs expressing the XCR1 chemokine receptor are characterised by their superior capability of antigen cross- presentation and priming of highly cytotoxic T lymphocyte (CTL) responses. Recently, XCR1 was found to be also expressed in tissue-residents DCs in humans, with a simitar transcriptional profile to that of cross- presenting murine DCs. This shed light into the value of harnessing this subtype of XCR1+ cross-presenting DCs for therapeutic vaccination of cancer. In this study, we explored ways of adjuvanting and optimising LSP therapeutic vaccinations by the use, in Part I, of the XCLl chemokine that selectively binds to the XCR1 receptor, as a mean to target antigen to the cross-presenting XCR1+ DCs; and in Part II, by the inclusion of Q.S21 in the LSP vaccine formulation, a saponin with adjuvant activity, as well as the ability to promote cytosolic delivery of LSP antigens due to its intrinsic cell membrane insertion activity. In Part I, we designed and produced XCLl-(OVA LSP)-Fc fusion proteins, and showed that their binding to XCR1+ DCs mediate their chemoattraction. In addition, therapeutic vaccinations adjuvanted with XCLl-(OVA LSP)-Fc fusion proteins significantly enhanced the OVA-specific CD8+ T cell response, and led to complete tumour regression in the EL4-OVA model, and significant control of tumour growth in the B16.0VA tumour model. With the aim to optimise the co-delivery of LSP antigen and XCLl to skin-draining lymph nodes we also tested immunisations using nanoparticle (NP)-conjugated OVA LSP in the presence or absence of XCLl chemokine. The NP-mediated delivery of LSP potentiated the CTL response seen in the blood of vaccinated mice, and NP-OVA LSP vaccine in the presence of XCLl led to higher blood frequencies of OVA-specific memory-precursor effector cells. Nevertheless, in these settings, the addition XCLl to NP-OVA LSP vaccine formulation did not increase its antitumour therapeutic effect. In the Part II, we assessed in HLA-A2/DR1 mice the immunogenicity of the Melan-AA27L LSP or the Melan-A26. 35 AA27l short synthetic peptide (SSP) used in conjunction with the saponin adjuvant QS21, aiming to identify a potent adjuvant formulation that elicits a quantitatively and qualitatively strong immune response to tumour antigens. We showed a high CTL immune response elicited by the use of Melan-A LSP or SSP with QS21, which both exerted similar killing capacity upon in vivo transfer of target cells expressing the Melan-A peptide in the context of HLA-A2 molecules. However, the response generated by the LSP immunisation comprised higher percentages of CD8+T cells of the central memory phenotype (CD44hl CD62L+ and CCR7+ CD62L+) than those of SSP immunisation, and most importantly, the strong LSP+QS21 response was strictly CD4+T cell-dependent, as shown upon CD4 T cell depletion. Altogether, these results suggest that both XCLl and QS21 may enhance the ability of LSP to prime CD8 specific T cell responses, and promote a long-term memory response. Therefore, these observations may have important implications for the design of protein or LSP-based cancer vaccines for specific immunotherapy of cancer -- Les vacans thérapeutiques contre le cancer visent à induire une forte et durable réponse immunitaire contre des cellules cancéreuses résiduelles. Cette réponse requiert la collaboration entre le système immunitaire inné, en particulier les cellules dendrites (DCs), et le système immunitaire adaptatif, en l'occurrence les lymphocytes TCD4 hdper et CD8 cytotoxiques. La mise au point d'adjuvants et de molécules mimant un agent pathogène tels les ligands TLRs ou d'autres agents facilitant l'internalisation d'antigènes, est essentielle pour casser la tolérance du système immunitaire contre les cellules cancéreuses afin de générer une réponse effectrice et mémoire contre la tumeur. L'utilisation de longs peptides synthétiques (LSPs) est une approche prometteuse du fait que leur présentation en tant qu'antigénes requiert leur internalisation et leur transformation par les cellules dendrites (DCs, qui sont les mieux à même d'éviter la tolérance immunitaire. Récemment une sous-population de DCs exprimant le récepteur XCR1 a été décrite comme ayant une capacité supérieure dans la cross-présentation d'antigènes, d'où un intérêt à développer des vaccins ciblant les DCs exprimant le XCR1. Durant ma thèse de doctorat, j'ai exploré différentes approches pour optimiser les vaccins avec LSPs. La première partie visait à cibler les XCR1-DCs à l'aide de la chemokine XCL1 spécifique du récepteur XCR1, soit sou s la forme de protéine de fusion XCL1-OVA LSP-Fc, soit associée à des nanoparticules. La deuxième partie a consisté à tester l'association des LSPs avec I adjuvant QS21 dérivant d'une saponine dans le but d'optimiser l'internalisation cytosolique des longs peptides. Les protéines de fusion XCLl-OVA-Fc développées dans la première partie de mon travail, ont démontré leur capacité de liaison spécifique sur les XCRl-DCs associée à leur capacité de chemo-attractio. Lorsque inclues dans une mmunisation de souris porteuse de tumeurs établies, ces protéines de fusion XCL1-0VA LSP-Fc et XCLl-Fc plus OVA LSP ont induites une forte réponse CDS OVA spécifique permettant la complète régression des tumeurs de modèle EL4- 0VA et un retard de croissance significatif de tumeurs de type B16-0VA. Dans le but d'optimiser le drainage des LSPs vers es noyaux lymphatiques, nous avons également testé les LSPs fixés de manière covalente à des nanoparticules co- injectees ou non avec la chemokine XCL1. Cette formulation a également permis une forte réponse CD8 accompagnée d'un effet thérapeutique significatif, mais l'addition de la chemokine XCL1 n'a pas ajouté d'effet anti-tumeur supplémentaire. Dans la deuxième partie de ma thèse, j'ai comparé l'immunogénicité de l'antigène humain Melan A soit sous la forme d un LSP incluant un épitope CD4 et CD8 ou sous la forme d'un peptide ne contenant que l'épitope CD8 (SSP) Les peptides ont été formulés avec l'adjuvant QS21 et testés dans un modèle de souris transgéniques pour les MHC let II humains, respectivement le HLA-A2 et DR1. Les deux peptides LSP et SSP ont généré une forte réponse CD8 similaire assoc.ee a une capacité cytotoxique équivalente lors du transfert in vivo de cellules cibles présentant le peptide SSP' Cependant les souris immunisées avec le Melan A LSP présentaient un pourcentage plus élevé de CD8 ayant un Phénotype «centra, memory» (CD44h' CD62L+ and CCR7+ CD62L+) que les souris immunisées avec le SSP, même dix mois après I'immunisation. Par ailleurs, la réponse CD8 au Melan A LSP était strictement dépendante des lymphocytes CD4, contrairement à l'immunisation par le Melan A SSP qui n'était pas affectée. Dans l'ensemble ces résultats suggèrent que la chemokine XCL1 et l'adjuvant QS21 améliorent la réponse CD8 à un long peptide synthétique, favorisant ainsi le développement d'une réponse anti-tumeur mémoire durable. Ces observations pourraient être utiles au développement de nouveau vaccins thérapeutiques contre les tumeurs.